Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases
Jonathan Mitchell, Niedzica Camacho, Patrick Shea, Konrad H. Stopsack, Vijai Joseph, Oliver Burren, Ryan Dhindsa, Abhishek Nag, Jacob E. Berchuck, Amanda O’Neill, Ali Abbasi, Anthony W. Zoghbi, Jesus Alegre-Díaz, Pablo Kuri-Morales, Jaime Berumen, Roberto Tapia-Conyer, Jonathan Emberson, Jason M. Torres, Rory Collins, Quanli Wang, David Goldstein, Athena Matakidou, Carolina Haefliger, Lauren Anderson-Dring, Ruth March, Vaidehi Jobanputra, Brian Dougherty, Keren Carss, Slavé Petrovski, Philip W. Kantoff, Kenneth Offit, Lorelei A. Mucci, Mark Pomerantz, Margarete A. Fabre
medRxiv 2024.05.10.24307164; doi: https://doi.org/10.1101/2024.05.10.24307164